Published On : July 2026
The cardiovascular healthcare value-based care models market is shaped as much by who is negotiating contracts as by which payment model is used. On one side sit four distinct payor archetypes, each with different incentives and risk tolerance; on the other sit four provider archetypes, each with different scale and negotiating leverage. This page classifies both sides of that equation and explains how they typically pair up.
Medicare, spanning both traditional fee-for-service beneficiaries attributed through ACOs and Medicare Advantage members enrolled directly with a plan, is the dominant payor category in cardiovascular VBC, reflecting both the age-related concentration of cardiovascular disease and CMS's sustained policy push toward risk-based contracting. National payors such as national payors such as Optum, Humana, and CVS Health operate some of the largest Medicare Advantage books tied to cardiology risk arrangements.
Commercial insurers participate more selectively, typically piloting cardiology value-based arrangements in markets with strong provider partners before scaling further. Medicaid managed care organizations are increasingly experimenting with cardiovascular risk models as states pursue broader value-based Medicaid transformation, though volume remains smaller than Medicare. Self-funded employer plans represent the newest and smallest payor category, generally entering cardiovascular VBC through third-party administrators or centers-of-excellence arrangements for complex cardiac procedures rather than building direct risk contracts.
Hospital-employed cardiology networks represent the largest provider category by market activity, benefiting from direct control over both the physician and facility sides of a cardiac episode, which simplifies bundled payment and risk contract execution. Integrated delivery networks extend this advantage further by combining hospitals, employed physicians, and often a health plan under one organizational umbrella, giving them the broadest control over the full cost and quality equation.
Independent cardiology groups retain meaningful market share but generally require external support, whether from an enablement platform, an MSO, or a consolidator, to build the risk-management infrastructure needed for anything beyond upside-only arrangements. Management services organizations and specialty care platforms fill this gap, providing shared analytics, contracting expertise, and administrative infrastructure that let independent groups participate in value-based contracts without merging into a hospital system or selling their practices outright.
The pairing between payor type and provider type strongly predicts which risk tier a given arrangement will use. Medicare Advantage plans working with integrated delivery networks or hospital-employed cardiology groups tend to move fastest and furthest toward two-sided risk and full capitation, because both sides already have the data infrastructure and scale needed to manage population-level cardiac risk. This is precisely the dynamic covered in more depth in the risk-sharing structures explained in our payment models guide, which details how upside-only, two-sided, and full capitation tiers map onto different organizational readiness levels.
Commercial insurers, by contrast, more often pair with independent cardiology groups or MSO-supported practices in earlier-stage, upside-only shared savings arrangements, reflecting both smaller attributed populations and a more cautious approach to downside risk on the provider side. Medicaid managed care arrangements frequently route through the same MSOs and enablement platforms that support independent groups in Medicare Advantage contracts, since the underlying infrastructure needs are similar even though the beneficiary population and quality priorities differ.
Self-funded employer plans typically intersect with the provider landscape differently again, often contracting directly with cardiology-specialized platforms or centers-of-excellence networks for defined high-cost procedures such as CABG, rather than building a continuous population-health relationship. Recognizing these typical pairings helps both payors and provider organizations identify realistic near-term partners rather than pursuing arrangements that are structurally mismatched to their current risk capacity.